Thursday - November 5, 2026

Compound for EGFR Kinase Inhibitor, Composition,

2026-11-03

ALEXANDRIA, Virginia, Nov. 3 -- INNOVATION INSTITUTE FOR ARTIFICIAL INTELLIGENCE IN MEDICINE OF ZHEJIANG UNIVERSITY, Hangzhou, China has been assigned a patent (No. US 12780851 B2, initially filed July 29, 2022) developed by eight inventors Qiaojun He, Hangzhou, China; Qinjie Weng, Hangzhou, China; Binhui Chen, Hangzhou, China; Fangjie Yan, Hangzhou, China; Jun Mo, Hangzhou, China; Chunxia Wu, Hangzhou, China; Rushuang Jin, Hangzhou, China; and Liying Yan, Hangzhou, China, for "Compound for EGF . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Compound for EGFR Kinase Inhibitor, Composition,

Information Request Form

Copyright Targeted News Service 2026